AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Stocks Moving Premarket: PPCB, BTAI, TNXP, DAY, TPIC, and Other Gainers & Losers
ByAinvest
Monday, Aug 18, 2025 7:27 am ET1min read
Propanc Biopharma Inc. (PPCB) is up 252% to $10.13, while TPI Composites Inc. (TPIC) is down 54% to $0.10 in premarket trading. Other notable movers include BioXcel Therapeutics Inc. (BTAI), up 20% to $6.57, and Tonix Pharmaceuticals Holding Corp. (TNXP), up 13% to $58.14.
Propanc Biopharma Inc. (PPCB) and TPI Composites Inc. (TPIC) are experiencing significant movements in premarket trading. Propanc Biopharma Inc. has seen a substantial increase, rising by 252% to $10.13, while TPI Composites Inc. has decreased by 54% to $0.10. Other notable movers include BioXcel Therapeutics Inc. (BTAI), which has gained 20% to $6.57, and Tonix Pharmaceuticals Holding Corp. (TNXP), which has increased by 13% to $58.14.Propanc Biopharma Inc. has been in the spotlight recently with its public offering and Nasdaq uplisting. The company announced a public offering of 1 million shares at $4.00 each, expecting to raise around $4 million before expenses. The offering is set to close on August 18, 2025, following the company's approval to list its common stock on the Nasdaq Capital Market, with trading anticipated to start on August 15, 2025 [2]. This move is expected to enhance the company's visibility and market access, potentially leading to increased liquidity and investment opportunities.
TPI Composites Inc., on the other hand, has been experiencing volatility. The company initiated voluntary Chapter 11 proceedings to facilitate restructuring and position the company for long-term success. The move was announced on August 14, 2025, following a series of financial challenges, including a Q2 loss and revenue estimates that were lagged [3]. The stock has been trading lower due to these developments.
Other notable movements include BioXcel Therapeutics Inc., which has seen a 20% increase, and Tonix Pharmaceuticals Holding Corp., which has gained 13%. These companies have been performing well in the market, with Tonix Pharmaceuticals Holding Corp. reaching a significant milestone with its stock price.
In conclusion, the premarket trading on July 2, 2025, has shown significant movements in the healthcare and biotechnology sectors. Propanc Biopharma Inc. and TPI Composites Inc. are leading the charge with their respective announcements and financial performances.
References:
[1] https://finviz.com/quote.ashx?t=PPCB
[2] https://www.quiverquant.com/news/Propanc+Biopharma%2C+Inc.+Announces+Public+Offering+of+Common+Stock+and+Nasdaq+Uplisting
[3] https://finviz.com/quote.ashx?t=TPIC
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet